Integrating proteomics and transcriptomics for the identification of potential targets in early colorectal cancer

Colorectal cancer (CRC) is one of the most common malignancies worldwide. At present, CRC can often be treated upon diagnosis at stage I or II, or when dysplasia is detected; however, 60-70% of cases are not diagnosed until they have developed into late stages of the disease or until the malignancy...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wang, Shi, Jian, Zhou, Yan, Liu, Tongjun, Zhan, Fangling, Zhang, Kai, Liu, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615923/
https://www.ncbi.nlm.nih.gov/pubmed/31268166
http://dx.doi.org/10.3892/ijo.2019.4833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615923/
https://www.ncbi.nlm.nih.gov/pubmed/31268166
http://dx.doi.org/10.3892/ijo.2019.4833

Ejemplares similares